Pinnacle Wealth Management Advisory Group LLC Sells 4,283 Shares of UnitedHealth Group Incorporated $UNH

Pinnacle Wealth Management Advisory Group LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 52.0% during the 1st quarter, HoldingsChannel reports. The firm owned 3,959 shares of the healthcare conglomerate’s stock after selling 4,283 shares during the quarter. Pinnacle Wealth Management Advisory Group LLC’s holdings in UnitedHealth Group were worth $1,071,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Oberndorf William E bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $12,276,000. Griffith & Werner Inc. acquired a new stake in shares of UnitedHealth Group during the third quarter worth approximately $3,039,000. Nordea Investment Management AB boosted its holdings in shares of UnitedHealth Group by 4.2% in the 4th quarter. Nordea Investment Management AB now owns 91,496 shares of the healthcare conglomerate’s stock worth $30,287,000 after acquiring an additional 3,720 shares in the last quarter. Rovida Advisors Inc. raised its position in UnitedHealth Group by 100.0% in the 3rd quarter. Rovida Advisors Inc. now owns 30,000 shares of the healthcare conglomerate’s stock valued at $10,358,000 after purchasing an additional 15,000 shares during the last quarter. Finally, Capital Research Global Investors grew its holdings in shares of UnitedHealth Group by 126.9% during the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock worth $4,503,419,000 after purchasing an additional 7,293,009 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $427.47 on Friday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $427.93. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. The stock has a market capitalization of $388.21 billion, a price-to-earnings ratio of 32.29, a PEG ratio of 1.72 and a beta of 0.64. The firm has a fifty day moving average of $383.92 and a two-hundred day moving average of $332.44.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter in the prior year, the company posted $7.20 earnings per share. The firm’s revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 18.32 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were issued a dividend of $2.32 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Monday, June 15th. UnitedHealth Group’s dividend payout ratio is presently 70.09%.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares in the company, valued at $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.28% of the company’s stock.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Wall Street sentiment remains constructive, with multiple firms reiterating bullish ratings and several recent price-target increases, including a new $475 target from BofA Securities. That suggests analysts see room for further upside as margins and Optum Health improve. What to Expect From UnitedHealth Group’s Q2 2026 Earnings Report
• Positive Sentiment: Investors appear to be rotating into healthcare as a defensive play while technology stocks weaken, which is supporting demand for UNH shares. Social-media chatter also points to continued interest in the company’s recovery narrative and its resilient insurance and medical-services business. UnitedHealth Group Stock (UNH) Opinions on Market Rotation and Analyst Upgrades
• Positive Sentiment: Market coverage ahead of the Q2 2026 report says analysts expect double-digit EPS growth, reinforcing the idea that earnings could justify the stock’s recent move higher. What to Expect From UnitedHealth Group’s Q2 2026 Earnings Report
• Neutral Sentiment: Recent articles also frame UNH as a long-term value and healthcare watchlist name, which supports investor interest but does not by itself add a fresh catalyst.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Royal Bank Of Canada lifted their price target on UnitedHealth Group from $361.00 to $400.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. TD Cowen reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Monday, June 22nd. Raymond James Financial upgraded shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price objective for the company in a research report on Wednesday, April 1st. Erste Group Bank upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, April 27th. Finally, Oppenheimer upped their price target on UnitedHealth Group from $385.00 to $405.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $410.79.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.